Europe

Moderna vaccine criticized for high cost, EU tries to lower price

The previously announced by the American company Moderna for its developed against  COVID-19 at $ 32-37 per dose is considered too high in the world, for which the company was criticized.

Writes about this The Guardian.

In addition, at first, its deliveries will be carried out mainly to the American market, since it was the US government that financed the development company for almost $2.5 billion to accelerate the development of the vaccine.

The publication notes that the Moderna vaccine is more expensive than Johnson & Johnson ($10) and Pfizer ($20).

The is already trying to negotiate a price reduction with the manufacturer of an effective vaccine, they expect a price below $25 per dose, Reuters writes, citing an official who participated in the relevant negotiations with the company.


Google News

Leave a Reply

Your email address will not be published. Required fields are marked *